Pralmorelin (GHRP-2) vs GHRP-6 (Growth Hormone Releasing Peptide-6) — Peptide Comparison
Pralmorelin (GHRP-2) vs GHRP-6 (Growth Hormone Releasing Peptide-6) — Peptide Comparison Pralmorelin (GHRP-2) vs GHRP-6 (Growth Hormone Releasing Peptide-6) — compare dosing, benefits, safety profiles, side effects, and how they stack. See which… At a Glance D
This comparison does not assign a generated winner or score.
Pralmorelin (GHRP-2) vs GHRP-6 (Growth Hormone Releasing Peptide-6) — Peptide Comparison Pralmorelin (GHRP-2) vs GHRP-6 (Growth Hormone Releasing Peptide-6) — compare dosing, benefits, safety profiles, side effects, and how they stack. See which… At a Glance Dose Range Pralmorelin (GHRP-2) 100–300 mcg GHRP-6 (Growth Hormone Releasing Peptide-6) Frequency Once daily Multiple times daily Administration Subcutaneous injection Cycle Length 4-6 weeks 8-12 weeks Onset Speed Rapid (hours to days) Moderate (1-2 weeks) Evidence Level Limited human trials Efficacy Muscle & Performance Enhancement Injury Recovery & Healing Diagnostic Clinical Use Muscle Recovery and Growth Cellular Health and Protection Appetite and Nutrient Intake Technical Data Molecular Formula C45H55N9O6 Molecular Weight 818.0 g/mol Half-Life 15-60 minutes Bioavailability ~100% (subcutaneous injection) CAS Number 158861-67-7 C46H56N12O6 873.0 g/mol ~2.5 hours <1% oral, high subcutaneous 87616-84-0 Protocols standard 1 mcg/kg/hour (continuous infusion) in research settings Continuous infusion Study-defined (e.g. ~270 minutes in published trials) Subcutaneous infusion dose used in controlled human GH-release/appetite studies; not an approved therapeutic regimen. [4] 100 mcg (0.1 mg) single bolus (diagnostic GH-stimulation test) Single administration Single test; blood sampled at 0, 15, 30, 60 min Japan-approved diagnostic dose (GHRP Kaken 100) for growth hormone deficiency; fixed 100 mcg IV bolus. A research GH-stimulation dose of 1 mcg/kg IV is also documented. [1] ~100 mcg per injection (approx. 1 mcg/kg) 1-3 times daily, on an empty stomach Open-ended in research practice Research-practice GH-secretagogue dosing; the ~100 mcg anchor reflects the validated 1 mcg/kg GH-saturating dose, though no isolated subcutaneous human dose-response trial exists [6]. 1 mcg/kg bolus (optionally followed by 1 mcg/kg/hr infusion) Single bolus for acute GH testing; infusion studies ran up to ~34 hours Acute test or infusion study Trial-established near-maximal GH-releasing intravenous dose in healthy men; pituitary responsiveness maintained over prolonged infusion [6]. Applications Athletes and Fitness Enthusiasts If you're serious about lean muscle gains and recovery, pralmorelin directly stimulates GH release—one of the body's most powerful anabolic hormones. Most athletes in research settings use 100-200 mcg for faster muscle repair and improved performance. Individuals Recovering from Injury Recent animal studies show GHRP-2 reduces inflammation and speeds tendon-bone healing. If you're dealing with sports injuries, rotator cuff issues, or fractures, this peptide's anti-inflammatory profile may accelerate recovery when combined with proper rehab. Those Seeking Diagnostic GH Testing If your doctor suspects growth hormone deficiency, pralmorelin is the gold-standard diagnostic tool in Japan and many countries. A single injection stimulates GH release, allowing physicians to assess your pituitary function safely and accurately. Peptide Research Enthusiasts Pralmorelin is one of the most extensively studied GHRPs worldwide. If you're exploring peptide protocols and understand research-grade products, this is a powerful tool for understanding how your GH axis responds to stimulation. Athletes and Serious Trainers If you're hitting the gym hard and want better recovery and muscle growth, GHRP-6 amplifies your body's natural GH response. This is particularly valuable during intense training phases when you want to maximize adaptation and minimize soreness. The appetite stimulation also helps you consume the calories you need to grow. Those Exploring Novel Peptide Protocols GHRP-6 offers a unique mechanism through the ghrelin receptor, making it valuable for users who want to explore diverse GH-stimulation pathways. It works distinctly from GHRH-based approaches and pairs well with other GH secretagogues for synergistic effects. Longevity and Metabolic Health Enthusiasts Growth hormone plays roles in metabolic health, body composition, and potentially aging markers. GHRP-6's emerging research on cellular protection and antioxidant activation makes it interesting for those interested in broader health optimization beyond just muscle growth. Safety Profile Common Facial flushing Transient headache Increased appetite Temporary dizziness or lightheadedness Uncommon Carpal tunnel-like sensations Joint or muscle aches Sleep quality changes Serious Severe allergic reaction (anaphylaxis) Increased Appetite Mild Joint or Muscle Discomfort Water Retention or Mild Swelling Sleep Disturbances Mild Dizziness or Lightheadedness Allergic Reaction Research Status FDA Status Research compound Safety Overview Pralmorelin (GHRP-2) has been safely used in diagnostic settings in Japan for decades and is well-tolerated in most individuals when used at appropriate doses. The peptide is synthetic and chemically stable, with low immunogenicity risk. However, it is NOT FDA approved and should only be used under medical supervision or within research protocols. Long-term safety data in healthy humans is limited. Contraindications xActive malignancy or unresolved cancer history xUncontrolled hypertension or severe cardiovascular disease xPregnancy or breastfeeding xAcute infection or sepsis xUncontrolled diabetes GHRP-6 has a relatively long research history dating back to 1981, with human studies demonstrating its ability to stimulate GH release. The good news is that animal safety studies show excellent tolerability at high doses, and the side effects reported are generally mild and reversible. However, it's not FDA-approved, so use is based on research evidence rather than pharmaceutical oversight. Always purchase from reputable sources and consider medical consultation, especially if you have existing health conditions. xKnown allergy or sensitivity to any component of the peptide xActive cancer or history of cancer without medical clearance xSevere cardiovascular disease or uncontrolled hypertension xAcute critical illness or sepsis Decision Guide Choose Pralmorelin (GHRP-2) if... Athletes seeking enhanced recovery and lean mass gains Individuals with suspected GH deficiency (diagnostic use) Recovery from tendon or bone injuries Those wanting to test GH axis responsiveness Choose GHRP-6 (Growth Hormone Releasing Peptide-6) if... Building lean muscle mass and improving body composition Recovery from intense training programs and athletic performance Supporting overall metabolic health and longevity markers Exploring novel GH-stimulation pathways for those who respond well to peptide protocols